Literature DB >> 19323077

[Incidence of metachronic contralateral inguinal hernia].

I Tuduri Limousin1, M J Moya Jiménez, J Morcillo Azcárate, R Granero Cendón, I Fernández Pineda, A Millán López, J C De Agustín Asensio.   

Abstract

INTRODUCTION: There are many observational studies about the incidence of metachronous contralateral inguinal hernia (MIH). Metaanalysis allows to resume the results of individual studies in one with a higher level of evidence. AIM: to know the incidence of MIH in order to decide the contralateral exploration.
MATERIAL AND METHODS: We do an extensive bibliographic review in Medline, Embase and Cochrane Central. Data analysis is done with RevMan 4.2.
RESULTS: 632 abstracts were screened by only one revisor who selected 27 studies: 17802 inguinal hernias and 1209 MIH. Follow up is between 6 months and 10 years. Due to high heterogeneity, a randomized effect analysis (Der Simonian and Lard) is done. The incidence of MIH is 6,96% (6,07-7,85); 14 hernia must be operated to avoid one MIH (NNT). If the original side of the hernia is left, the probability of MIH is 1.81 times higher (NNT =10). The secondary analysis indicates that there is no important publication bias.
CONCLUSIONS: Rutinary bilateral inguinal exploration is not justified. Only in high anaesthetic risk patients, bilateral exploration should be suggested.

Entities:  

Mesh:

Year:  2009        PMID: 19323077

Source DB:  PubMed          Journal:  Cir Pediatr        ISSN: 0214-1221


  2 in total

1.  Incidence of and Risk Factors for Pediatric Metachronous Contralateral Inguinal Hernia: Analysis of a 17-Year Nationwide Database in Taiwan.

Authors:  Cheng-Hung Lee; Yun Chen; Chi-Fu Cheng; Chao-Lin Yao; Jin-Chia Wu; Wen-Yao Yin; Jian-Han Chen
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

2.  Is it worth to explore the contralateral side in unilateral childhood inguinal hernia?: A PRISMA-compliant meta-analysis.

Authors:  Ralph F Staerkle; Laura C Guglielmetti; Isabella N Bielicki; Stefan Gaukel; Giovanni Frongia; Sarah Hilton; Lukas Fink; Raphael N Vuille-Dit-Bille
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.